X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ALKEM LABORATORIES NATCO PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 32.7 - - View Chart
P/BV x 16.6 6.1 270.8% View Chart
Dividend Yield % 0.7 0.7 97.5%  

Financials

 NATCO PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ALKEM LABORATORIES
Mar-16
NATCO PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs8771,589 55.2%   
Low Rs4241,232 34.4%   
Sales per share (Unadj.) Rs223.4417.5 53.5%  
Earnings per share (Unadj.) Rs31.156.3 55.2%  
Cash flow per share (Unadj.) Rs40.364.7 62.2%  
Dividends per share (Unadj.) Rs5.0012.70 39.4%  
Dividend yield (eoy) %0.80.9 85.4%  
Book value per share (Unadj.) Rs219.5292.9 74.9%  
Shares outstanding (eoy) m33.07119.57 27.7%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.93.4 86.1%   
Avg P/E ratio x20.925.1 83.5%  
P/CF ratio (eoy) x16.121.8 74.1%  
Price / Book Value ratio x3.04.8 61.5%  
Dividend payout %16.122.6 71.3%   
Avg Mkt Cap Rs m21,504168,653 12.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1289,171 12.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,38949,915 14.8%  
Other income Rs m1671,645 10.2%   
Total revenues Rs m7,55651,561 14.7%   
Gross profit Rs m1,7938,482 21.1%  
Depreciation Rs m3041,006 30.3%   
Interest Rs m366671 54.6%   
Profit before tax Rs m1,2908,451 15.3%   
Minority Interest Rs m46-114 -40.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3091,606 19.2%   
Profit after tax Rs m1,0276,731 15.3%  
Gross profit margin %24.317.0 142.8%  
Effective tax rate %23.919.0 125.9%   
Net profit margin %13.913.5 103.1%  
BALANCE SHEET DATA
Current assets Rs m3,68127,062 13.6%   
Current liabilities Rs m3,12315,324 20.4%   
Net working cap to sales %7.623.5 32.1%  
Current ratio x1.21.8 66.8%  
Inventory Days Days8967 134.5%  
Debtors Days Days5941 142.2%  
Net fixed assets Rs m7,68512,610 60.9%   
Share capital Rs m331239 138.3%   
"Free" reserves Rs m6,67034,490 19.3%   
Net worth Rs m7,25935,027 20.7%   
Long term debt Rs m9551,212 78.8%   
Total assets Rs m11,95754,387 22.0%  
Interest coverage x4.513.6 33.2%   
Debt to equity ratio x0.10 380.3%  
Sales to assets ratio x0.60.9 67.3%   
Return on assets %11.713.6 85.6%  
Return on equity %14.219.2 73.7%  
Return on capital %20.724.9 83.4%  
Exports to sales %39.412.9 304.0%   
Imports to sales %5.73.1 184.7%   
Exports (fob) Rs m2,9086,461 45.0%   
Imports (cif) Rs m4211,540 27.3%   
Fx inflow Rs m3,4456,563 52.5%   
Fx outflow Rs m7033,012 23.3%   
Net fx Rs m2,7433,552 77.2%   
CASH FLOW
From Operations Rs m1,4407,259 19.8%  
From Investments Rs m-1,0891,864 -58.4%  
From Financial Activity Rs m-353-9,273 3.8%  
Net Cashflow Rs m-1-150 1.0%  

Share Holding

Indian Promoters % 52.0 66.9 77.8%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 33.1 23.7%  
FIIs % 16.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 0.0 -  
Shareholders   25,395 68,381 37.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare NATCO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 23, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS